Industry: Chemical & Material
Published Date: 2026-03-05
Pages: 132 Pages
Report ld: 6007869
Request Sample
Customized Report
Iohexol Market Size(US$)

CAGR 2026-2032
6.9%
Market Size,2032
USD 1,140
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Iohexol market was valued at US$ 719 million in 2025 and is anticipated to reach US$ 1140 million by 2032, at a CAGR of 6.9% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Iohexol competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Iohexol is a non-ionic, iodinated radiocontrast agent used to enhance visibility of anatomical structures in X-ray based imaging procedures (CT, angiography, myelography, urography, joint studies and other contrast-enhanced scans). The active pharmaceutical ingredient (API) — chemically an organoiodine compound — is supplied to formulators of finished contrast media (sterile injectable solutions, oral/rectal solutions for bowel studies, or intrathecal preparations) and, in some cases, to manufacturers of specialty laboratory reagents that use iodinated density media. In commercial terms the “Iohexol API market” therefore covers: production and sale of technical- and pharmaceutical-grade Iohexol (including batches certified to pharmacopeial standards); regulatory documentation such as Drug Master Files (DMFs) and certificates of analysis supplied to finished product manufacturers; contract manufacturing (CMO) and custom synthesis for brand and generic contrast media producers; and the downstream finished-dosage contrast media market that ultimately consumes the API.
Iohexol sold into the pharmaceutical channel must meet stringent purity, identity, and particulate/sterility standards appropriate for parenteral use; producers commonly supply documentation aligned with pharmacopeial monographs and regulatory expectations for injectable contrast media. Because finished contrast products are administered intravenously, intrathecally, or orally for diagnostic imaging, the API’s manufacturing process, residual solvent profile, heavy-metal content, and impurity profile are central to market acceptability. Compliance with pharmacopeial monographs and the ability to support regulatory filings (e.g., provision of a US DMF, CEP for EU markets, or equivalent dossiers) are usual entry barriers for suppliers.
In 2024, global Iohexol production reached approximately 5,545.5 MT, with an average global market price of around US$ 121.5 per kg. The global single-line production capacity ranges from 500 to 800 MT per year. The industry's gross profit margin is approximately 35%-45%.
Demand for Iohexol is driven by the global use of contrast-enhanced imaging in hospitals, outpatient imaging centers, interventional radiology, cardiology suites, and surgical planning. The primary use is in computed tomography (CT) angiography and general CT imaging to delineate blood vessels, organs, and lesions; it is also used in intrathecal myelography and specialized procedures. Growth drivers on the demand side typically include expansion of medical imaging capacity (new CT installations and interventional suites), ageing populations with higher imaging utilization, rising incidence and detection of chronic diseases (cardiovascular disease, cancer), and broader adoption of minimally invasive image-guided procedures that require high-quality contrast agents. In many clinical pathways, contrast media are integral to diagnostic accuracy, so demand is relatively inelastic to small price fluctuations — although procurement practice and tendering by hospitals, health systems, and large distributors can exert strong price pressure.
The Iohexol market is a technically and regulatory-intensive niche within the broader contrast media and radiopharmaceutical supply chain. Its demand is underpinned by durable clinical needs — diagnostic CT and image-guided procedures — with steady growth driven by demographic changes and expanding global imaging capacity. Market developments will be shaped by: regulatory expectations (pharmacopeial alignment, DMFs), procurement behavior (tendering and generic competition), supplier capability (GMP/DMF/CEP credentials), and regional investment in imaging infrastructure. While substitution risk is limited for many CT applications, cost pressure, supply reliability, and environmental/regulatory compliance will continue to drive supplier consolidation, vertical integration, and selective capacity investments. For new entrants, the combination of capital-intensive quality systems and the need to support regulatory dossiers makes the market accessible mainly to established API manufacturers or CMOs that can rapidly meet pharmacopeial and regulatory demands.
Global key manufacturers of Iohexol include GE Healthcare, Otsuka Chemicals, Starry, etc. Global top three manufacturers hold a share about 85%.
This report delivers a comprehensive overview of the global Iohexol market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Iohexol. The Iohexol market size, estimates, and forecasts are provided in terms of output/shipments (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Iohexol market comprehensively. Regional market sizes by Type, by Application, by Purity and Quality Grade, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Iohexol manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Purity and Quality Grade, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Iohexol manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Iohexol production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Iohexol consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Iohexol Market Overview
1.1 Product Definition
1.2 Iohexol by Type
1.2.1 Global Iohexol Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Iohexol by Purity and Quality Grade
1.3.1 Global Iohexol Market Value Growth Rate Analysis by Purity and Quality Grade: 2025 vs 2032
1.3.2 Pharmaceutical Grade (GMP-Grade)
1.3.3 Technical or Laboratory Grade
1.3.4 Custom Purity Grades
1.4 Iohexol by Assay (Content of Iohexol)
1.4.1 Global Iohexol Market Value Growth Rate Analysis by Assay (Content of Iohexol): 2025 vs 2032
1.4.2 Standard Assay (≥ 99.0%)
1.4.3 High Assay (≥ 99.5%)
1.4.4 Research or Technical Grade (≥ 97–98%)
1.5 Iohexol by Application
1.5.1 Global Iohexol Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.5.2 Contrast Agents
1.5.3 Diagnostic Agents
1.5.4 Others
1.6 Global Market Growth Prospects
1.6.1 Global Iohexol Production Value Estimates and Forecasts (2021–2032)
1.6.2 Global Iohexol Production Capacity Estimates and Forecasts (2021–2032)
1.6.3 Global Iohexol Production Estimates and Forecasts (2021–2032)
1.6.4 Global Iohexol Market Average Price Estimates and Forecasts (2021–2032)
1.7 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Iohexol Production Market Share by Manufacturers (2021–2026)
2.2 Global Iohexol Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Iohexol, Industry Ranking, 2024 vs 2025
2.4 Global Iohexol Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Iohexol Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Iohexol, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Iohexol, Product Offerings and Applications
2.8 Global Key Manufacturers of Iohexol, Date of Entry into the Industry
2.9 Iohexol Market Competitive Situation and Trends
2.9.1 Iohexol Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Iohexol Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Iohexol Production by Region
3.1 Global Iohexol Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Iohexol Production Value by Region (2021–2032)
3.2.1 Global Iohexol Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Iohexol by Region (2027–2032)
3.3 Global Iohexol Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Iohexol Production Volume by Region (2021–2032)
3.4.1 Global Iohexol Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Iohexol by Region (2027–2032)
3.5 Global Iohexol Market Price Analysis by Region (2021–2032)
3.6 Global Iohexol Production, Value, and Year-over-Year Growth
3.6.1 North America Iohexol Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Iohexol Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Iohexol Production Value Estimates and Forecasts (2021–2032)
4 Iohexol Consumption by Region
4.1 Global Iohexol Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Iohexol Consumption by Region (2021–2032)
4.2.1 Global Iohexol Consumption by Region (2021–2026)
4.2.2 Global Iohexol Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Iohexol Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Iohexol Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Iohexol Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Iohexol Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Iohexol Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Iohexol Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Iohexol Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Iohexol Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Iohexol Production by Type (2021–2032)
5.1.1 Global Iohexol Production by Type (2021–2026)
5.1.2 Global Iohexol Production by Type (2027–2032)
5.1.3 Global Iohexol Production Market Share by Type (2021–2032)
5.2 Global Iohexol Production Value by Type (2021–2032)
5.2.1 Global Iohexol Production Value by Type (2021–2026)
5.2.2 Global Iohexol Production Value by Type (2027–2032)
5.2.3 Global Iohexol Production Value Market Share by Type (2021–2032)
5.3 Global Iohexol Price by Type (2021–2032)
6 Segment by Application
6.1 Global Iohexol Production by Application (2021–2032)
6.1.1 Global Iohexol Production by Application (2021–2026)
6.1.2 Global Iohexol Production by Application (2027–2032)
6.1.3 Global Iohexol Production Market Share by Application (2021–2032)
6.2 Global Iohexol Production Value by Application (2021–2032)
6.2.1 Global Iohexol Production Value by Application (2021–2026)
6.2.2 Global Iohexol Production Value by Application (2027–2032)
6.2.3 Global Iohexol Production Value Market Share by Application (2021–2032)
6.3 Global Iohexol Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Zhejiang Hichi Pharmaceutical
7.1.1 Zhejiang Hichi Pharmaceutical Iohexol Company Information
7.1.2 Zhejiang Hichi Pharmaceutical Iohexol Product Portfolio
7.1.3 Zhejiang Hichi Pharmaceutical Iohexol Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Zhejiang Hichi Pharmaceutical Main Business and Markets Served
7.1.5 Zhejiang Hichi Pharmaceutical Recent Developments/Updates
7.2 GE Healthcare
7.2.1 GE Healthcare Iohexol Company Information
7.2.2 GE Healthcare Iohexol Product Portfolio
7.2.3 GE Healthcare Iohexol Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 GE Healthcare Main Business and Markets Served
7.2.5 GE Healthcare Recent Developments/Updates
7.3 Zhejiang Starry Pharmaceutical
7.3.1 Zhejiang Starry Pharmaceutical Iohexol Company Information
7.3.2 Zhejiang Starry Pharmaceutical Iohexol Product Portfolio
7.3.3 Zhejiang Starry Pharmaceutical Iohexol Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Zhejiang Starry Pharmaceutical Main Business and Markets Served
7.3.5 Zhejiang Starry Pharmaceutical Recent Developments/Updates
7.4 Otsuka Chemicals
7.4.1 Otsuka Chemicals Iohexol Company Information
7.4.2 Otsuka Chemicals Iohexol Product Portfolio
7.4.3 Otsuka Chemicals Iohexol Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Otsuka Chemicals Main Business and Markets Served
7.4.5 Otsuka Chemicals Recent Developments/Updates
7.5 Justesa Imagen
7.5.1 Justesa Imagen Iohexol Company Information
7.5.2 Justesa Imagen Iohexol Product Portfolio
7.5.3 Justesa Imagen Iohexol Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Justesa Imagen Main Business and Markets Served
7.5.5 Justesa Imagen Recent Developments/Updates
7.6 Beijing Beilu Pharmaceutical
7.6.1 Beijing Beilu Pharmaceutical Iohexol Company Information
7.6.2 Beijing Beilu Pharmaceutical Iohexol Product Portfolio
7.6.3 Beijing Beilu Pharmaceutical Iohexol Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Beijing Beilu Pharmaceutical Main Business and Markets Served
7.6.5 Beijing Beilu Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Iohexol Industry Chain Analysis
8.2 Iohexol Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Iohexol Production Modes and Processes
8.4 Iohexol Sales and Marketing
8.4.1 Iohexol Sales Channels
8.4.2 Iohexol Distributors
8.5 Iohexol Customer Analysis
9 Iohexol Market Dynamics
9.1 Iohexol Industry Trends
9.2 Iohexol Market Drivers
9.3 Iohexol Market Challenges
9.4 Iohexol Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Iohexol market size was US$ 719 million in 2025 and is forecast to reach a readjusted size of US$ 1140 million by 2032 with a CAGR of 6.9% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 76
USD 4250.00
(Single User License)
The global Iohexol market is projected to grow from US$ 719 million in 2025 to US$ 1140 million by 2032, at a CAGR of 6.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 142
USD 4900.00
(Single User License)
The global market for Iohexol was estimated to be worth US$ 719 million in 2025 and is projected to reach US$ 1140 million, growing at a CAGR of 6.9% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 95
USD 3950.00
(Single User License)
The global market for Iohexol was estimated to be worth US$ 674 million in 2024 and is forecast to a readjusted size of US$ 1073 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-10-29
Pages: 109
USD 3950.00
(Single User License)
The global Iohexol market is projected to grow from US$ 674 million in 2024 to US$ 1073 million by 2031, at a CAGR of 6.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-29
Pages: 131
USD 4900.00
(Single User License)
The global Iohexol market size was US$ 674 million in 2024 and is forecast to a readjusted size of US$ 1073 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-10-29
Pages: 77
USD 4250.00
(Single User License)
The global market for Iohexol was valued at US$ 674 million in the year 2024 and is projected to reach a revised size of US$ 1073 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published Date: 2025-10-29
Pages: 93
USD 2900.00
(Single User License)
The global market for Iohexol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 95
USD 3950.00
(Single User License)
Iohexol (CAS 66108-95-0)
Published Date: 2024-01-31
Pages: 85
USD 2900.00
(Single User License)
Iohexol (CAS 66108-95-0)
Published Date: 2024-01-16
Pages: 98
USD 3950.00
(Single User License)
The global Iohexol market size was US$ 719 million in 2025 and is forecast to reach a readjusted size of US$ 1140 million by 2032 with a CAGR of 6.9% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 76
The global Iohexol market is projected to grow from US$ 719 million in 2025 to US$ 1140 million by 2032, at a CAGR of 6.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 142
The global market for Iohexol was estimated to be worth US$ 719 million in 2025 and is projected to reach US$ 1140 million, growing at a CAGR of 6.9% from 2026 to 2032.
Published: 2026-03-05
Pages: 95
The global market for Iohexol was estimated to be worth US$ 674 million in 2024 and is forecast to a readjusted size of US$ 1073 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-10-29
Pages: 109
The global Iohexol market is projected to grow from US$ 674 million in 2024 to US$ 1073 million by 2031, at a CAGR of 6.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-29
Pages: 131
The global Iohexol market size was US$ 674 million in 2024 and is forecast to a readjusted size of US$ 1073 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-10-29
Pages: 77
The global market for Iohexol was valued at US$ 674 million in the year 2024 and is projected to reach a revised size of US$ 1073 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published: 2025-10-29
Pages: 93
The global market for Iohexol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 95
Iohexol (CAS 66108-95-0)
Published: 2024-01-31
Pages: 85
Iohexol (CAS 66108-95-0)
Published: 2024-01-16
Pages: 98
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now